Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Two loss years in a row NBB
Negative result in 2024 and 2025.
-
Figures corrected NBB
Corrected annual account filed for 2023.
Financials
Financial year 2025
CANCER STATE THERAPEUTICS from Charleroi, company number BE0793113273, closed financial year 2025 with a result of € -690,490 after tax. For that financial year CANCER STATE THERAPEUTICS recorded a gross margin of € -105,252 and equity of € 3.7 million. Compared with financial year 2024, the result moved from € -451,570 to € -690,490. The company made a loss. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on May 15, 2026.
€ 3.7 million
▲ € 3.3 million vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -690,490
▼ 53 % more loss than in 2024
Profit after tax over the fiscal year.
€ 171,917
▼ 53% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -1.5 million.
People and assets in 2025
€ 593,089
▲ 120% vs 2024
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 28,185
▼ 73% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 55,491
▲ 62% vs 2024
Wages, holiday pay and social contributions still to pay. No outstanding taxes.
| 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|
| Gross margin | € -186,642 | € -114,896 | € -105,252 | ▲ € 9,645 |
| Profit after taxes | € -330,453 | € -451,570 | € -690,490 | ▼ € 238,920 |
| Equity | € 880,722 | € 429,152 | € 3,738,662 | ▲ € 3.3 million |
| Total debts | € 467,165 | € 170,937 | € 222,178 | ▲ 30% |
| Cash | € 760,439 | € 365,382 | € 171,917 | ▼ 53% |
| Retained profit | € -330,453 | € -782,023 | € -1,472,513 | ▼ € 690,490 |
| Balance sheet total | € 1,347,887 | € 600,089 | € 3,960,840 | ▲ € 3.4 million |
By gross margin, CANCER STATE THERAPEUTICS ranks 19th of 23 companies with main activity “Speur- en ontwikkelingswerk op biotechnologisch gebied” in Charleroi that publish figures (fiscal year 2025).
Key figures of CANCER STATE THERAPEUTICS, fiscal years 2023 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
Ask about CANCER STATE THERAPEUTICS the way you would ask their accountant.
Answers from the filed annual accounts, the Belgian Official Gazette and the CBE register.
Connect ChatGPT or Claude for free- ChatGPT
- Claude
Free account, no payment card. Key figures unlimited, the annual accounts and deeds of 10 companies a month. Need more? Get in touch, we are looking for our first pilot users.
What happened to CANCER STATE THERAPEUTICS?
What happened at CANCER STATE THERAPEUTICS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Capital increase of € 4 million, published in the Gazette. Source: Staatsblad ↗
- New annual accounts for financial year 2025: loss of € 690,490. Source: NBB ↗
- Capital increase of € 4 million, published in the Gazette. Source: Staatsblad ↗
- Pierre Chevalier became a director. NBB
- François Delvaux became a director. NBB
- Capital increase of € 1.2 million, published in the Gazette. Source: Staatsblad ↗
- Incorporation, published in the Gazette. Source: Staatsblad ↗
- New establishment in Charleroi. KBO
In short
From € 330,453 loss in 2023 to € 690,490 loss in 2025.
Management
Behind CANCER STATE THERAPEUTICS are Ahmed Fahim, Gaetan Waucquez, Pierre Chevalier, Jean-Claude Marian, Cédric Blanpain and François Delvaux. Gaetan Waucquez is also behind ARLON 32. Pierre Chevalier is also behind Cristallerie du Val Saint Lambert, GEORGE FORREST EUROPE, VOSSENSTEERT and GROUPE FORREST INTERNATIONAL.
Directors
According to the 2025 annual accounts
Ahmed Fahim
Director
Pierre Chevalier
Director
Also active at: Cristallerie du Val Saint Lambert, GEORGE FORREST EUROPE, VOSSENSTEERT, GROUPE FORREST INTERNATIONAL
since 2025
Jean-Claude Marian
Director
Cédric Blanpain
Managing director
François Delvaux
Director
since 2025
Establishments
Establishment units
Physical locations of this company
Rue Auguste Piccard 48
6041 Charleroi
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 6 companies are registered at this address.
All companies at this address →SYNABS
€ 742,551 gross margin · 2025
European Infrared Technologies
€ 53,354 gross margin · 2024
HEARTKINETICS
€ -463,720 gross margin · 2022
Genflow Biosciences
€ -264,246 gross margin · 2025
NEUVASQ BIOTECHNOLOGIES
€ 641,586 gross margin · 2025
+1 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Similar companies in Charleroi
Same main activity (Speur- en ontwikkelingswerk op biotechnologisch gebied), 28 active companies in Charleroi, largest first.
€ 8 million gross margin · 2023
€ 4.2 million gross margin · 2025
€ 1.5 million gross margin · 2025
€ 991,461 gross margin · 2025
€ 742,551 gross margin · 2025
€ 393,338 gross margin · 2024
Shareholders according to the Official Gazette deeds
Who contributed at incorporation and at capital increases, with the deed as source. Later share transfers are not published in the Gazette.
Capital increase
Source: Deed ↗- MARIAN Jean-Claude(intekenaar) 4.9%
- FORREST George(intekenaar) 1.8%
- E-MERGE(intekenaar) 1.3%
- CORNET de WAYS-RUART Paul(intekenaar) 0.9%
- OSCAR(intekenaar) 0.9%
- EMHC(intekenaar) 0.9%
- PETER Françoise(intekenaar) 0.5%
- de PRET ROOSE de CALESBERG Denise(intekenaar) 0.5%
- MULTIFIN(intekenaar) 0.4%
- HEDO Gregory(intekenaar) 0.4%
- LIPPENS Maurice(intekenaar) 0.3%
- SALIK Brigitte(intekenaar) 0.3%
- MARINVEST(intekenaar) 0.3%
- BLANPAIN Marc(intekenaar) 0.2%
- DELVAUX Bernard(intekenaar) 0.2%
- WAUCQUEZ Gaëtan(intekenaar) 0.1%
- FAHIM Ahmed(intekenaar) 0.1%
- ZAJFEN Alain(intekenaar) 0.1%
- THE OMAR AL-MIDANI LIVING TRUST(intekenaar) 0.1%
- FRANCO Alexandre(intekenaar) 0.1%
- WAUCQUEZ Charles-Henry(intekenaar) 0%
- WAUCQUEZ Clément(intekenaar) 0%
Capital increase
Source: Deed ↗- MARIAN Jean-Claude(inschrijver) 5.7%
- FORREST George(inschrijver) 2.1%
- E-MERGE(inschrijver) 1.6%
- CORNET de WAYS-RUART Paul(inschrijver) 1%
- OSCAR(inschrijver) 1%
- EMHC(inschrijver) 1%
- PETER Françoise(inschrijver) 0.6%
- de PRET ROOSE de CALESBERG Denise(inschrijver) 0.6%
- MULTIFIN(inschrijver) 0.5%
- HEDO Gregory(inschrijver) 0.5%
- SALIK Brigitte(inschrijver) 0.3%
- LIPPENS Maurice(inschrijver) 0.3%
- MARINVEST(inschrijver) 0.3%
- DELVAUX Bernard(inschrijver) 0.2%
- BLANPAIN Marc(inschrijver) 0.2%
- WAUCQUEZ Gaëtan(inschrijver) 0.1%
- FAHIM Ahmed(inschrijver) 0.1%
- ZAJFEN Alain(inschrijver) 0.1%
- AL-MIDANI Omar(inschrijver) 0.1%
- FRANCO Alexandre(inschrijver) 0.1%
- WAUCQUEZ Charles-Henry(inschrijver) 0%
- WAUCQUEZ Clément(inschrijver) 0%
Capital increase
Source: Deed ↗- MARIAN Jean-Claude Charles Louis Roger(intekenaar kapitaalverhoging) 4%
- FORREST George Arthur(intekenaar kapitaalverhoging) 4%
- BOUAMATOU KHOUNA Mohamed Hamayenne(intekenaar kapitaalverhoging) 3%
- SALIK Brigitte Hélène(intekenaar kapitaalverhoging) 2%
- HEDO Grégory(intekenaar kapitaalverhoging) 2%
- MULTIFIN(intekenaar kapitaalverhoging (société anonyme)) 2%
- WAUCQUEZ Gaëtan Eric Ghislain Michel César Ghislain(intekenaar kapitaalverhoging) 1.4%
- LIPPENS Maurice Robert Josse Marie Ghislain(intekenaar kapitaalverhoging) 1%
- WAUCQUEZ Charles-Henry Gabriel Sylvius Marie Ghislain(intekenaar kapitaalverhoging) 0.8%
- WAUCQUEZ Clement Amaury(intekenaar kapitaalverhoging) 0.8%
- BLANPAIN Marc Yves(intekenaar kapitaalverhoging) 0.5%
- VAN de VYVERE Philippe François Pierre(intekenaar kapitaalverhoging) 0.5%
- ZAJFEN Alain(intekenaar kapitaalverhoging) 0.5%
- FRANCO Alexandre(intekenaar kapitaalverhoging) 0.5%
- FAHIM Ahmed(intekenaar kapitaalverhoging) 0.5%
- AL-MIDANI Omar Mouaffak(intekenaar kapitaalverhoging als trustee van THE OMAR AL-MIDANI LIVING TRUST) 0.5%
Incorporation
Source: Deed ↗- BLANPAIN Cédric(oprichter) 100%
Details
- Company number
- 0793.113.273
- VAT number
- BE 0793.113.273
- Registered office
- Rue Auguste Piccard 48, 6041 Charleroi
- Names & denominations
- CANCER STATE THERAPEUTICS
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 28 October 2022
- Peppol
- Active · Active since 9 Nov 2022
- Activities · NACE
Speur- en ontwikkelingswerk op biotechnologisch gebied
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied